AMLX: Milne George M Jr sold $831K of stock
By AlphaYouPublished Form 4
MILNE GEORGE M JR
Reporting filer
Milne George M Jr reported selling 30,000 shares of Amylyx Pharmaceuticals, Inc. for about $831K ($27.70 a share on average). Form 4 filed Oct 7, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | MILNE GEORGE M JR | 2026-10-05 | S | Sale | 30000 | 27.6968 | 782,881 | 2 days | Filed terms
|
Common Stock
- Owner
- MILNE GEORGE M JR
- Date
- 2026-10-05
- Code
- S
- Action
- Sale
- Quantity
- 30000
- Price
- 27.6968
- Following holdings
- 782,881
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 30000
- transaction Price Per Share: 27.6968
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 782881
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- MILNE GEORGE M JR: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 28, 2026.
- F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.36 to $28.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Original sources
Prepared automatically from public filing data. Report a correction.